Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 7, 2014, Pages 1336-1342

  Onal, Cem ^a   Reyhan, Mehmet ^a   Guler, Ozan C ^a   Yapar, Ali Fuat ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cervical cancer; Chemotherapy; Gynecological cancer; Positron emission tomography; Radiotherapy

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPLETE METABOLIC RESPONSE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METABOLIC PARAMETERS; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CANCER; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; MIDDLE AGED; PROGNOSIS; RADIOGRAPHY; SCINTISCANNING; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; FEMALE; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84903725602     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2719-5     Document Type: Article

References (26)

1. Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol. 2006;101:147-51. doi:10.1016/j.ygyno.2005.10.005.
2. Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007;298:2289-95. doi:10.1001/jama.298.19.2289. (Pubitemid 350146219)
3. Onal C, Reyhan M, Parlak C, Guler OC, Oymak E. Prognostic Value of Pretreatment 18F-fluorodeoxyglucose Uptake in Patients With Cervical Cancer Treated With Definitive Chemoradiotherapy. Int J Gynecol Cancer. 2013;23:1104 - 10. doi :10.1097/IGC.0b013e3182989483.
4. Chung HH, Nam BH, Kim JW, Kang KW, Park NH, Song YS, et al. Preoperative [18 F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer. Eur J Nucl Med Mol Imaging. 2010;37:1467-73. doi:10.1007/s00259-010-1413-5.
5. Chung HH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, et al. Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer. Eur J Radiol. 2012;81:e817-22. doi:10.1016/j.ejrad.2012.02.015.
6. Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2012;83:185-90. doi:10.1016/j.ijrobp.2011.05.053.
7. Beriwal S, Kannan N, Sukumvanich P, Richard SD, Kelley JL, Edwards RP, et al. Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence. Gynecol Oncol. 2012;127:303-6. doi:10.1016/j.ygyno.2012.08.006.
8. Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Luttmann S, et al. Survival of cervical cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. Acta Oncol. 2012;51:915-21. doi:10.3109/0284186X.2012.708105.
9. Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, et al. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009;28:95. doi:10.1186/1756-9966-28-95.
10. Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys. 2004;60:1160-72. doi:10.1016/j.ijrobp.2004.04.032. (Pubitemid 39440802)
11. Onal C, Oymak E, Findikcioglu A, Reyhan M. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer. Int J Gynecol Cancer. 2013;23:337-42. doi:10.1097/IGC.0b013e31827e00cc.
12. Signorelli M, Guerra L, Montanelli L, Crivellaro C, Buda A, Dell'Anna T, et al. Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? Gynecol Oncol. 2011;123:236-40. doi:10.1016/j.ygyno.2011.07.096.
13. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-80. doi:10.1200/JCO.2004.07.197. (Pubitemid 41103599)
14. Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer. 2007;17:833-42. doi:10.1111/j.1525-1438.2007.00895. x. (Pubitemid 47063341)
15. Narayan K, Fisher RJ, Bernshaw D, Shakher R, Hicks RJ. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer. 2009;19:912-8. doi:10.1111/IGC.0b013e3181a58d3f.
16. Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol. 2006;103:165-70. doi:10.1016/j.ygyno. 2006.02.016. (Pubitemid 44374686)
17. Grigsby PW, Siegel BA, Dehdashti F, Mutch DG. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys. 2003;55:907-13. (Pubitemid 36286992)
18. Park TK, Kwon JY, Kim SW, Kim SH, Kim SN, Kim GE. Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma. Int J Clin Oncol. 2004;9:120-4. doi:10.1007/s10147-003-0378-9. (Pubitemid 38619326)
19. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol. 2007;107:310-5. doi:10.1016/j.ygyno.2007.06.026. (Pubitemid 47575730)
20. Ma DJ, Zhu JM, Grigsby PW. Tumor volume discrepancies between FDG-PET and MRI for cervical cancer. Radiother Oncol. 2011;98: 139-42. doi:10.1016/j. radonc.2010.10.004.
21. Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004;22: 2167-71. doi:10.1200/JCO.2004.09. 035. (Pubitemid 41095151)
22. Gupta T, Master Z, Kannan S, Agarwal JP, Ghsoh-Laskar S, Rangarajan V, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38: 2083-95. doi:10.1007/s00259-011-1893-y.
23. Siva S, Herschtal A, Thomas JM, Bernshaw DM, Gill S, Hicks RJ, et al. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer. Cancer. 2011;117:3981-8. doi:10.1002/cncr.25991.
24. Elit L, Fyles AW, Oliver TK, Devries-Aboud MC. Fung-Kee-Fung M, members of the Gynecology Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based C. Follow-up for women after treatment for cervical cancer. Curr Oncol. 2010;17:65-9.
25. Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. Cervical cancer. J Natl Compr Cancer Netw JNCCN. 2010;8:1388-416.
26. Sartori E, Pasinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol. 2007;107:S241-7. doi:10.1016/j.ygyno.2007.07. 025. (Pubitemid 47483865)